SNV4818 is an oral treatment currently being evaluated in an early and mid-stage study for breast cancer and other advanced ...

Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick ...

LONDON, March 16 (Reuters) - (This March 16 story has been corrected to say 'data and analytics company,' not 'ratings agency,' when referring to Moody's in paragraph 25) War in the Middle East is ...

Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can ...

Three hours inland from Chennai, India, traffic crawls on a half-finished road past rice fields and cow crossings until it reaches a newer complex of neat white buildings. Among them is the cancer ...

The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...

Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...

On Tuesday, Israel struck a major pharmaceutical factory in Tehran that is one of the country’s top producers of cancer drugs ...

A dual cannabinoid agonist drug candidate is being investigated for its potential in treating wasting syndrome in cancer patients. It demonstrated a weight gain in patients who took the drug versus a ...

Shares of Oric Pharmaceuticals sank 40% Wednesday after the cancer biotech reported study results that were positive--but not positive enough for Wall Street. In an early-stage trial, Oric’s prostate- ...

(In March 16 story, removes "ratings agency" in final paragraph and corrects to "data and analytics company") By Maggie Fick ...